INSPECS Group plc Stock
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
03:35:11 07/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 87.50 GBX | -1.13% |
|
-1.13% | +22.38% |
| 11/09 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 10/09 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 128M 115M 105M 95.53M 180M 12B 186M 1.26B 503M 6.4B 479M 469M 20.22B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 83.59M 74.97M 68.52M 62.55M 118M 7.86B 122M 826M 329M 4.19B 314M 307M 13.24B | EV / Sales 2026 * |
0.31x | EV / Sales 2027 * | 0.3x |
| Free-Float |
10.75% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 04/03 | Form 8.3 - Inspecs Group Plc | AQ |
| 11/02 | Form 8.3 - Inspecs Group Plc | AQ |
| 09/02 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 28/01 | Form 8.3 - Inspecs Group Plc | AQ |
| 07/01 | Form 8.3 - Inspecs Group Plc | AQ |
| 1 day | -1.13% | ||
| 1 week | -1.13% | ||
| Current month | -1.13% | ||
| 1 month | -2.78% | ||
| 3 months | -9.79% | ||
| 6 months | +4.79% | ||
| Current year | +22.38% |
| 1 week | 87 |  | 90 |
| 1 month | 87 | | 93 |
| Current year | 60 | | 105 |
| 1 year | 60 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 01/12/2022 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Johnson
BRD | Director/Board Member | 64 | 19/05/2026 |
| Chairman | 66 | 01/12/2022 | |
Richard Peck
BRD | Director/Board Member | 62 | 10/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/6/25 | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 4/6/25 | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 8/11/22 | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -1.13% | +25.00% | +5.42% | 128M | |
| -3.23% | +3.51% | -13.00% | +15.96% | 190B | |
| -2.90% | +5.45% | +10.41% | +40.45% | 125B | |
| -2.75% | +11.65% | -8.47% | +18.50% | 124B | |
| +0.96% | +5.15% | -37.16% | +12.09% | 99.31B | |
| -1.80% | +0.82% | -7.52% | +70.12% | 63.65B | |
| -0.78% | +7.07% | +19.14% | -17.27% | 57.71B | |
| +0.79% | +22.65% | -4.57% | +60.02% | 53.26B | |
| -6.98% | -14.56% | -11.97% | +46.23% | 47.03B | |
| -2.36% | +3.72% | +3.86% | -7.99% | 36.15B | |
| Average | -2.02% | +4.63% | -2.43% | +24.35% | 79.63B | |
| Weighted average by Cap. | -2.20% | +5.71% | -7.48% | +25.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 240M 219M 200M 377M 25.11B 389M 2.64B 1.05B 13.4B 1B 981M 42.3B | 277M 248M 227M 207M 390M 26.01B 402M 2.73B 1.09B 13.88B 1.04B 1.02B 43.82B |
| Net income | - | - |
| Net Debt | -44.08M -39.53M -36.13M -32.98M -62.14M -4.14B -64.1M -435M -174M -2.21B -165M -162M -6.98B | -45.44M -40.75M -37.25M -34M -64.06M -4.27B -66.08M -449M -179M -2.28B -171M -167M -7.19B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | GBX 87.50 | -1.13% | 11,762 |
| 05/11/26 | GBX 88.50 | 0.00% | 3 |
| 04/11/26 | GBX 88.50 | 0.00% | 0 |
| 03/11/26 | GBX 88.50 | 0.00% | 0 |
| 02/11/26 | GBX 88.50 | 0.00% | 9,008 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.169USD
Average target price
0.8180USD
Spread / Average Target
-30.05%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
